Performance Forecast - The company expects a net profit attributable to shareholders of approximately 130 million to 180 million yuan, representing an increase of 144.29% to 238.25% compared to the same period last year, which was 53.2152 million yuan [1] - The net profit after deducting non-recurring gains and losses is expected to be between 121 million and 171 million yuan, an increase of 92.79% to 172.45% compared to last year's 62.764 million yuan [1] Reasons for Performance Change - The significant growth in performance is driven by the company's proactive market engagement, expansion of customer channels, and enhanced refined management, which have strengthened its core competitiveness [1] - The company has optimized its product structure, improved market layout, and strengthened cost control, leading to increased revenue and gross profit in its non-sartan raw materials, intermediates, CDMO business, and formulation business [1] - The company has effectively reduced losses by significantly cutting back on foreign exchange derivative trading [1] Non-Recurring Gains and Losses - The estimated impact of non-recurring gains and losses on the net profit attributable to shareholders is approximately 9 million yuan, primarily from government subsidies [2] Audit Status - The performance forecast has not been audited by an accounting firm, and specific financial data will be disclosed in the company's 2025 semi-annual report [1][2]
天宇股份: 2025半年度业绩预告